The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Invited Commentary: Insulin Resistance Syndrome? Syndrome X? Multiple Metabolic Syndrome? A Syndrome At All? Factor Analysis Reveals Patterns in the Fabric of Correlated Metabolic Risk Factors
Abstract
Factor analysis has emerged as a useful method for understanding patterns underlying the co-occurrence of metabolic risk factors for both type 2 diabetes and atherosclerosis--often referred to as "insulin resistance syndrome." In factor analysis of data on 322 healthy elderly people from the Cardiovascular Health Study, Sakkinen et al. (Am J Epidemiol 2000;152:897-907) confirmed findings from a dozen prior studies that as many as four distinct physiologic domains comprise the syndrome, with a unifying role for markers of insulin resistance. With the addition of markers of hemostasis and inflammation, they also found that impaired fibrinolysis and endothelial dysfunction are central features of the syndrome, while inflammation is only weakly linked to insulin resistance through associations with obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Applied Multivariate Statistics for the Social Sciences
Stevens, J. P. (2012) · Routledge eBooks · doi:10.4324/9780203843130 · Cited by 10,648
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 837
Chronic Multisymptom Illness Affecting Air Force Veterans of the Gulf War
Fukuda, K. (1998) · JAMA · doi:10.1001/jama.280.11.981 · Cited by 729
Clustering of metabolic factors and coronary heart disease
Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712
Haffner, S. M. (1990) · JAMA · doi:10.1001/jama.1990.03440210043030 · Cited by 668 · cited 1×
“This concept—that there exists a unique metabolic syndrome arising from tissue resistance to insulin—was put forth about a decade ago on the basis of both controlled clinical (1) and epidemiologic ( 2 ) observations.”
BackgroundBody mass index, diabetes, and C-reactive protein among U.S. adults.
Ford, E. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1971 · Cited by 644
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study
Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P. M., Lipinska, I., D'Agostino, R. B., & Wilson, P. W. F. (2000) · JAMA · doi:10.1001/jama.283.2.221 · Cited by 538
Self-citation
Cited by
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
The metabolic syndrome: prevalence in worldwide populations
Cameron, A. J., Shaw, J. E., & Zimmet, P. Z. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.005 · Cited by 1,000
Coughlin, S. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.02.021 · Cited by 842
Childhood Overweight, Obesity, and the Metabolic Syndrome in Developing Countries
Kelishadi, R. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm003 · Cited by 628
A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
Ford, E. S., & Giles, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.575 · Cited by 616
Components of the “Metabolic Syndrome” and Incidence of Type 2 Diabetes
Hanson, R. L., Imperatore, G., Bennett, P. H., & Knowler, W. C. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3120 · Cited by 590
Defining Obesity Cut Points in a Multiethnic Population
Razak, F., Anand, S. S., Shannon, H., Vuksan, V., Davis, B., Jacobs, R., Teo, K. K., McQueen, M., & Yusuf, S. (2007) · Circulation · doi:10.1161/circulationaha.106.635011 · Cited by 558
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study
Azizi, F., Salehi, P., Etemadi, A., & Zahedi-Asl, S. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00066-4 · Cited by 526
Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Johnson, R. J., Perez-Pozo, S. E., Sautin, Y. Y., Manitius, J., Sanchez-Lozada, L. G., Feig, D. I., Shafiu, M., Segal, M., Glassock, R. J., Shimada, M., et al. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0033 · Cited by 505
Allostatic load as a predictor of functional decline
Karlamangla, A. S., Singer, B. H., McEwen, B. S., Rowe, J. W., & Seeman, T. E. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00399-2 · Cited by 483
Sedentary Lifestyle, Poor Cardiorespiratory Fitness, and the Metabolic Syndrome
LAKKA, T. A., LAAKSONEN, D. E., LAKKA, H.-M., M??NNIKK??, N., NISKANEN, L. K., RAURAMAA, R., & SALONEN, J. T. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000079076.74931.9a · Cited by 472
The Metabolic Syndrome: More Than the Sum of Its Parts?
Reilly, M. P., & Rader, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000088846.10655.e0 · Cited by 465
Meigs, J. B., Wilson, P. W. F., Nathan, D. M., D’Agostino, R. B., Williams, K., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2160 · Cited by 464
Self-citationCorrespondence analysis is a useful tool to uncover the relationships among categorical variables
Sourial, N., Wolfson, C., Zhu, B., Quail, J., Fletcher, J., Karunananthan, S., Bandeen-Roche, K., Béland, F., & Bergman, H. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.08.008 · Cited by 441
Nonalcoholic fatty liver disease and the metabolic syndrome
Marchesini, G., Marzocchi, R., Agostini, F., & Bugianesi, E. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174153.53683.f2 · Cited by 418
Magge, S. N., Goodman, E., Armstrong, S. C., COMMITTEE ON NUTRITION, ENDOCRINOLOGY, S. O., OBESITY, S. O., Daniels, S., Corkins, M., de Ferranti, S., Golden, N. H., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1603 · Cited by 401
Lee, D.-H., Lee, I.-K., Porta, M., Steffes, M., & Jacobs, D. R. (2007) · Diabetologia · doi:10.1007/s00125-007-0755-4 · Cited by 366
Perez-Pozo, S. E., Schold, J., Nakagawa, T., Sánchez-Lozada, L. G., Johnson, R. J., & Lillo, J. L. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.259 · Cited by 344
Carroll, S., & Dudfield, M. (2004) · Sports Medicine · doi:10.2165/00007256-200434060-00004 · Cited by 327
Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
Gerich, J. E. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1306 · Cited by 321
Sannigrahi, S., Pilla, F., Basu, B., Basu, A. S., & Molter, A. (2020) · Sustainable Cities and Society · doi:10.1016/j.scs.2020.102418 · Cited by 317
Ford, E. S., & Li, C. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.07.056 · Cited by 313
Metabolic and Additional Vascular Effects of Thiazolidinediones
Martens, F. M. A. C., Visseren, F. L. J., Lemay, J., de Koning, E. J. P., & Rabelink, T. J. (2002) · Drugs · doi:10.2165/00003495-200262100-00004 · Cited by 291
Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
Reaven, G. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030087 · Cited by 284
Biessels, G. J., & Kappelle, L. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331041 · Cited by 266
Goodman, E., Daniels, S. R., Morrison, J. A., Huang, B., & Dolan, L. M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.04.059 · Cited by 264
Factor Analysis of Metabolic Syndrome Using Directly Measured Insulin Sensitivity
Hanley, A. J. G., Karter, A. J., Festa, A., D’Agostino, R., Wagenknecht, L. E., Savage, P., Tracy, R. P., Saad, M. F., & Haffner, S. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2642 · Cited by 229
Goodman, E., Dolan, L. M., Morrison, J. A., & Daniels, S. R. (2005) · Circulation · doi:10.1161/01.cir.0000161957.34198.2b · Cited by 213
Mediterranean food pattern and the primary prevention of chronic disease: recent developments
Martinez-Gonzalez, M. A., Bes-Rastrollo, M., Serra-Majem, L., Lairon, D., Estruch, R., & Trichopoulou, A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00172.x · Cited by 200
Metabolic and Inflammation Variable Clusters and Prediction of Type 2 Diabetes
Hanley, A. J. G., Festa, A., D’Agostino, R. B., Wagenknecht, L. E., Savage, P. J., Tracy, R. P., Saad, M. F., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1773 · Cited by 198
Kang, S. M., Yoon, J. W., Ahn, H. Y., Kim, S. Y., Lee, K. H., Shin, H., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027694 · Cited by 197
Reilly, M. P., Wolfe, M. L., Rhodes, T., Girman, C., Mehta, N., & Rader, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000138740.84883.9c · Cited by 185
“695 mmol/L (150 mg/dL), (3) low HDL TABLE 1.”
BackgroundMethodInfluentialYudkin, J. S., Juhan-Vague, I., Hawe, E., Humphries, S. E., di Minno, G., Margaglione, M., Tremoli, E., Kooistra, T., Morange, P. E., Lundman, P., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2004.02.004 · Cited by 153
Sánchez-Taínta, A., Estruch, R., Bulló, M., Corella, D., Gómez-Gracia, E., Fiol, M., Algorta, J., Covas, M.-I., Lapetra, J., Zazpe, I., et al. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328308ba61 · Cited by 144
How Are Biomarkers Related to Physical and Mental Well-Being?
Seplaki, C. L., Goldman, N., Weinstein, M., & Lin, Y.-H. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.b201 · Cited by 104
Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology
Yudkin, J. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0711-3 · Cited by 75
Assies, J., Lok, A., Bockting, C. L., Weverling, G. J., Lieverse, R., Visser, I., Abeling, N. G. G. M., Duran, M., & Schene, A. H. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.12.009 · Cited by 72
Phenotypic, genetic, and genome-wide structure in the metabolic syndrome
Martin, L. J., North, K. E., Dyer, T., Blangero, J., Comuzzie, A. G., & Williams, J. (2003) · BMC Genetics · doi:10.1186/1471-2156-4-s1-s95 · Cited by 31
“Because we were unable to consider glucose or insulin, and because the properties of the variables chosen for analysis can unduly influence the results [15], it is not known whether SBP would remain as pivotal when considered in combination with glucose or insulin.”
Background
Metadata
- Authors
- Meigs, J. B.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-11-15
- Volume
- 152
- Issue
- 10
- Pages
- 908-911
- ISSN
- 0002-9262 (ISSN-L)
- OpenAlex
- W2029897333
- Cited by
- 401
- References
- 43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.